A listing of U.S. post marketing commitment clinical trials under investigation that are currently recruiting patients or pending recruitment can be found below. For additional information on these trials, including information on potential patient participation in these trials, please click on the links provided.
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
There is also an additional Pfizer-sponsored, investigational, pregabalin study that is recruiting patients in the United States that is not post marketing commitment:
For a listing of all ongoing clinical trials for Lyrica or to enroll a patient(s) in additional ongoing Lyrica clinical trials, please go to www.clinicaltrials.gov and search for ‘Lyrica’ or ‘pregabalin’.